Ulla Hald Buhl

Ulla Hald Buhl is a seasoned executive in the biotechnology and oncology sectors, currently serving as Chief Executive Officer and Board Member at Aida Oncology since September 2021, and as Chief Operating Officer and Board Member for Chosa Oncology since March 2022. With a strong focus on personalized cancer therapy, Ulla has held various leadership roles, including Executive Chairman at Cessatech A/S and Founder of 2X Oncology Inc. Ulla's extensive experience includes significant contributions to Allarity Therapeutics and Oncology Venture ApS, along with advisory positions in multiple organizations such as Marigold Innovation and Open Entrepreneurship DK. Ulla possesses a solid educational background, holding a Bachelor's degree in Nursing and a Diploma in Healthcare Sector Management.